CITIGROUP INC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2021$7,832,000
+2.9%
7,832,0000.0%0.01%0.0%
Q1 2021$7,608,000
+2.8%
7,832,0000.0%0.01%
+25.0%
Q4 2020$7,404,000
+3.5%
7,832,0000.0%0.00%
-20.0%
Q3 2020$7,152,000
+0.7%
7,832,0000.0%0.01%
-16.7%
Q2 2020$7,100,000
+1.8%
7,832,0000.0%0.01%0.0%
Q1 2020$6,973,000
+2.5%
7,832,0000.0%0.01%
+20.0%
Q4 2019$6,806,000
+9.9%
7,832,0000.0%0.01%0.0%
Q3 2019$6,193,000
-17.3%
7,832,0000.0%0.01%
-16.7%
Q2 2019$7,485,000
+0.3%
7,832,0000.0%0.01%
-14.3%
Q1 2019$7,463,000
+0.2%
7,832,0000.0%0.01%
-12.5%
Q4 2018$7,445,000
-0.6%
7,832,000
-0.6%
0.01%
+14.3%
Q3 2018$7,489,000
+8.8%
7,882,000
-1.3%
0.01%
+16.7%
Q2 2018$6,883,000
+6.9%
7,982,0000.0%0.01%
+20.0%
Q1 2018$6,436,000
-16.4%
7,982,0000.0%0.01%
-16.7%
Q4 2017$7,698,000
+92.4%
7,982,000
+66.2%
0.01%
+100.0%
Q3 2017$4,001,000
-26.0%
4,802,0000.0%0.00%
-40.0%
Q2 2017$5,408,000
-34.5%
4,802,000
-7.2%
0.01%
-28.6%
Q1 2017$8,262,000
+84.4%
5,172,0000.0%0.01%
+75.0%
Q4 2016$4,480,0005,172,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,014,000$29,401,0001.13%
UBS OCONNOR LLC 8,000,000$7,440,000,0000.15%
WHITEBOX ADVISORS LLC 5,000,000$4,727,0000.15%
ANGELO GORDON & CO., L.P. 1,397,000$1,321,0000.12%
INGALLS & SNYDER LLC 500,000$474,0000.02%
CITIGROUP INC 7,832,000$7,404,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders